We are live on
!
Find out more
HPCM
Hein Park Capital Management Portfolio holdings
AUM
$50.2M
1-Year Est. Return
17.7%
This Fund
S&P 500
This Quarter
Est. Return
-8.99%
1 Year Est. Return
+17.7%
3 Year Est. Return
+122.05%
5 Year Est. Return
+108.09%
10 Year Est. Return
–
AUM
$130M
AUM Growth
-$10.4M
(-7.4%)
Cap. Flow
-$1.35M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Surgery Partners
SGRY
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diebold Nixdorf
DBD
|
+$31.2M |
| 2 |
Bausch Health
BHC
|
+$1.65K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 67.22% |
| 2 | Healthcare | 30% |
Similar funds
7IH
FTB
GCM
GIA
HEC
MC
LCM
SIM
Hein Park Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Hein Park Capital Management held 4 positions worth $130M, down 7.4% from $141M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hein Park Capital Management's Q4 2024 filing shows 1 new and 2 reduced positions. Its largest new stake was Surgery Partners: 1,139,227 shares worth $24.1M. The largest sale was Diebold Nixdorf, an estimated $31.2M.
By sector, the portfolio is most concentrated in Technology at 67% of assets, down from 87% a quarter earlier, followed by Healthcare.
- Hein Park Capital Management's largest Q4 2024 buy was Surgery Partners: 1,139,227 shares worth $24.1M.
- Hein Park Capital Management's biggest Q4 2024 reduction was Diebold Nixdorf, cutting an estimated $31.2M.
- Hein Park Capital Management's ten largest holdings make up 100% of its $130M portfolio in Q4 2024.
- Hein Park Capital Management opened 1 new position and closed 0 in Q4 2024.
- Hein Park Capital Management's portfolio value fell 7.4% quarter-over-quarter to $130M.
Based on Hein Park Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.